Hyrax Biosciences

01/08/2016

MSF has seen 10% resistance to 1st line ARV treatment at its SA sites and up to 30% resistance to 2nd line treatments in Kenya, Malawi and Mozambique. This war is far from won. https://www.theguardian.com/global-development/2016/jul/31/aids-epidemic-getting-worse-drug-resistance-cost

The 2000 Aids conference in Durban shocked the world into action. Now, a new crisis looms, one fuelled by drug resistance, costly treatments and the lack of power many women have in sexual relationships

25/07/2016

We're hiring! Looking for an awesome senior developer to join our growing team. https://hyraxbio.co.za/who-we-are/careers/

Hyrax Biosciences is an award-winning early-stage bioinformatics company, specialising in high-performance software that analyses DNA for HIV and TB drug resistance testing. This is an exciting opportunity for an experienced web developer to join the team, as we begin to expand the scope of our prod...

12/07/2016

Read what Hyrax's Imogen Wright has to say about how science and business can play nicely

Science and business don't often go together, but that's changing as more scientists realise that their best ideas can be commercialised.

29/06/2016

A simple explanation of what we do in HIV... and why Imogen Wright has just walked away with 2nd place in the Innovation Prize for Africa competition

eNCA Latest news updates from around Africa

11/05/2016

More on exatype and the IPA Prize nomination! http://www.timeslive.co.za/thetimes/2016/05/11/Software-will-help-doctors-in-Aids-battle

Doctors may soon have a new weapon in their arsenal to fight antiretroviral resistance .

10/05/2016

http://www.engineeringnews.co.za/article/two-sa-doctors-make-top-10-nominations-for-innovation-prize-for-africa-2016-ceremony-2016-05-09

Two South African doctors are among the ten people nominated for the Innovation Prize for Africa, the African Innovation Foundation announced on Monday. South Africans Dr Imogen Wright (South Africa), who invented Exatype – a software solution that enables healthcare workers to determine HIV positiv...

09/05/2016

Hyrax's Imogen Wright recognised with other awesome innovators as a top 10 finalist in the Innovation for Africa Prize 2016!!!
http://www.forbes.com/sites/tobyshapshak/2016/05/07/exclusive-real-solutions-to-real-problems-named-in-innovation-prize-for-africa-2016-finalists/

African ingenuity this year showcases breakthroughs in malaria and other public health burdens, smart solutions for farmers and dynamic power initiatives …

14/04/2016

Latest from the AMR review highlights the important role of surveillance in the fight against antibiotic resistance.
'interventions to prevent and monitor
the development and spread of drug resistance are some of
the most prudent actions we can possibly take.'
http://amr-review.org/sites/default/files/Health%20infrastructure%20and%20surveillance%20final%20version_LR_NO%20CROPS.pdf

31/03/2016

Some info on what we are about in genomeweb
https://www.genomeweb.com/informatics/south-african-startup-hyrax-biosciences-launches-software-hiv-drug-resistance-testing

The company'sExatype software is a web-based solution for locating HIV drug resistance mutations using raw NGS data and other functional information.

31/03/2016

http://www.iol.co.za/capetimes/uwc-hiv-drug-resistance-test-innovation-1986693

undefined

25/06/2015

http://ewn.co.za/Media/2015/06/08/Concern-increases-over-a-decline-in-HIV-awareness-in-SA

Health Department spokesman Joe Maila says a decline in HIV awareness in the country has been noted with concern.

25/06/2015

http://www.sciencemag.org/content/early/2015/06/17/science.aac4223?utm_source=twitter&utm_medium=social&utm_campaign=twitter

A challenge for HIV-1 immunogen design is inducing neutralizing antibodies (NAbs) against neutralization-resistant (Tier-2) viruses that dominate human transmissions. We show that a soluble recombinant HIV-1 envelope glycoprotein trimer that adopts a native conformation (BG505 SOSIP.664) induced NAb…